Early studies evaluating TRAIL agonist-induced apoptosis in breast cancer cell lines revealed that while the MDA-MB-231 cell line was sensitive to the rapid induction of caspase dependent apoptosis, most of the cell lines tested were resistant to TRAIL-mediated apoptosis [26,58,89,90,91]. The gene discussed is TNFSF10; the disease is breast cancer.